Clinical Trial Update: Revaccination With PNEUMOVAX(TM) 23 in Older Adults (V110-007) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating revaccination with PNEUMOVAX 23 in older adults has completed and results were posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Infection

Drugs mentioned

• Pneumovax 23 (Pneumococcal polysaccharide vaccine 23-valent)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Pneumococcal Infection | Phase 3 | Status: COMPLETED | Results posted: 2009-05-25